Conclusion: This study establishes that a novel 32P brachytherapy device is easily deliverable via EUS. In combination with gemcitabine chemotherapy this is a tolerable and potentially effective treatment for locally inoperable pancreatic cancer. A study escalating the radiation dose used is planned.
PSD Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.